In cardiac physiology, preload is the end diastolic volume that stretches the right or left ventricle of the heart to its greatest dimensions under variable physiologic demand. It is defined as the length of the heart muscle just before it starts to pump and is measured clinically by the volume of blood in the left ventricle, the main pumping chamber, when it is most relaxed. Preload failure occurs when the maximal exercise-induced cardiac output (CO) is decreased without a concomitant increase in right heart or pulmonary vascular pressures.
Preload failure is associated with exercise intolerance in myalgic encephalomyelitis, chronic fatigue syndrome, orthostatic hypotension, and postural orthostatic tachycardia. David Systrom at Brigham Women's Hospital in Boston is currently trialing the use of Mestinon in patients with preload failure.
Learn more[edit | edit source]
- 2018, Advancements in ME/CFS Research, David M. Systrom, MD; Brigham and Women's Hospital | ME/CFSAlert 98 (Interview)
References[edit | edit source]
- Oliveira, Rudolf K.; Tracy, Julie A.; Karin, Abbey L.; Waxman, Aaron; Systrom, David (May 1, 2016). "Pyridostigmine for Exercise Intolerance Treatment in Preload Failure". American Thoracic Society International Conference Abstracts. American Thoracic Society: A5664–A5664. doi:10.1164/ajrccm-conference.2016.193.1_meetingabstracts.a5664.
- "The Exercise Response to Pharmacologic Cholinergic Stimulation in Preload Failure - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Retrieved Apr 8, 2019.